-
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study
Biotech Newswire
April 07, 2024
Touchlight announced an agreement with University of Liverpool for the use of dbDNA in the development of a fully-personalised therapeuticneoantigen DNA vaccine for patients with non-small cell lung cancer.
-
Live Biotherapeutics: Targeting The Microbiome For The Cancer Treatment
Shruti Talashi
March 18, 2024
The quest to create microbial products that can influence cancer outcomes has been rekindled by the mounting evidence of the role that microbiota plays in human health and illness.
-
Cancer-Fighting CAR-T Cell Immunotherapy Potentially Induces New Cancers: An Analysis of Potential Safety Challenges
Big Cat of Medical Field
March 06, 2024
Recent reports have indicated that the National Medical Products Administration has addressed the potential carcinogenicity associated with CAR-T cell immunotherapy.
-
Against Liver Cancer, Statins Helps Novel Liver Cancer Drug Development
Yuntian/PharmaSources
April 20, 2023
Statins help to improve liver cancer and have been confirmed by a large number of clinical and scientific trials.
-
Immune Drug Combination Therapies for Liver Cancer: Analysis of the Clinical Studies of the Two Approved and Two First-line Drug Combinations
PharmaSources/Yuntian
May 31, 2021
Liver cancer has recently drawn much attention by a Chinese movie star Ng Man-tat who died of liver cancer and the National Liver Day on Mar. 18.
-
Development of Anticancer Drugs for Ferroptosis: An Analysis of Representative Natural Products
PharmaSources/Yuntian
May 08, 2021
Over the past years, anticancer strategies based on ferroptosis have been well acknowledged, leading to a boom in the development of anticancer drugs at home and abroad.
-
O-drug Approved as First-line Immunotherapy for Gastric Cancer and What Other Domestic Counterparts to Expect
PharmaSources/Yefenghong
May 08, 2021
O-drug is the first approved immunotherapy for first-line treatment of gastric cancer.
-
KRAS - Hot Cancer Target Inhibitors in Developing
Neeta Ratanghayra
March 22, 2021
Mutant oncogenes play a key role in driving cancer progression, and this fact has set the stage for the discovery of targeted anticancer therapies.
-
The tumor disappears after infection with coronavirus! Looking at the “killing cancer with the virus” concept in the oncology field
PharmaSources/Wang Hong
January 21, 2021
The world is full of wonders. According to an article published by a British doctor in the British Journal of Haematology two days ago, a malignant lymphoma patient’s tumor almost disappeared after infection with coronavirus!
-
Chinese-Produced Anticancer Drugs Granted Designations by the FDA
PharmaSources/Xiaobin
February 08, 2021
As we wave goodbye to 2020 and embrace the arrival of 2021, it’s time for us to review, sum-up, and outlook.